MK-886 - A NOVEL MECHANISM, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR

被引：0
|
作者：
GILLARD, JW
MORTON, HE
DIXON, R
EVANS, J
FORTIN, R
GAUTHIER, JY
MACFARLANE, C
MILLER, D
ROUZER, C
VICKERS, P
FORDHUTCHINSON, AW
机构：
[1] MERCK FROSST CTR THERAPEUT RES,POINTE CLAIRE H9R 4PB,QUEBEC,CANADA
[2] MERCK & CO INC,RAHWAY,NJ 07065
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1990年 / 199卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：150 / MEDI
相关论文
共 50 条
  • [31] AZELASTINE - A NOVEL IN-VIVO INHIBITOR OF LEUKOTRIENE BIOSYNTHESIS - A POSSIBLE MECHANISM OF ACTION - A MINI REVIEW
    CHAND, N
    SOFIA, RD
    JOURNAL OF ASTHMA, 1995, 32 (03) : 227 - 234
  • [32] Computational Insights into the Inhibitory Mechanism of Human AKT1 by an Orally Active Inhibitor, MK-2206
    Rehan, Mohd
    Beg, Mohd A.
    Parveen, Shadma
    Damanhouri, Ghazi A.
    Zaher, Galila F.
    PLOS ONE, 2014, 9 (10):
  • [33] Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis
    Van Wauwe, J
    Aerts, F
    Cools, M
    Deroose, F
    Freyne, E
    Goossens, J
    Hermans, B
    Lacrampe, J
    Van Genechten, H
    Van Gerven, F
    Van Nyen, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (02): : 655 - 661
  • [34] A NOVEL NONPEPTIDIC, ORALLY ACTIVE RENIN INHIBITOR
    MORISHIMA, H
    KOIKE, Y
    NAKANO, M
    ATSUUMI, S
    TANAKA, S
    FUNABASHI, H
    HASHIMOTO, J
    SAWASAKI, Y
    MINO, N
    NAKANO, M
    MATSUSHIMA, K
    NAKAMICHI, K
    YANO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) : 999 - 1005
  • [35] AN ORALLY ACTIVE INHIBITOR OF LEUKOTRIENE SYNTHESIS ACCELERATES HEALING IN A RAT MODEL OF COLITIS
    WALLACE, JL
    KEENAN, CM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04): : G527 - G534
  • [36] ASSESSMENT OF THE IN-VIVO BIOCHEMICAL EFFICACY OF ORALLY-ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITORS
    TAGARI, P
    BRIDEAU, C
    CHAN, C
    FRENETTE, R
    BLACK, C
    FORDHUTCHINSON, A
    AGENTS AND ACTIONS, 1993, 40 (1-2): : 62 - 71
  • [37] HEMODYNAMIC MECHANISM OF ACTION OF A NOVEL, NONPEPTIDIC, AND ORALLY ACTIVE RENIN INHIBITOR IN ANESTHETIZED DOGS
    CALZADILLA, SV
    WESSALE, JL
    KLEINERT, HD
    KOVAR, PJ
    BOYD, SA
    BAKER, WR
    FASEB JOURNAL, 1992, 6 (04): : A1293 - A1293
  • [38] Effect of a leukotriene inhibitor (MK886) on nitric oxide and hydrogen peroxide production by macrophages of acutely and chronically stressed mice
    Sforcin, Jose Mauricio
    Nunes, Gladston A.
    Missima, Fabiane
    Sa-Nunes, Anderson
    Faccioli, Lucia H.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (09) : 1249 - 1254
  • [39] Mechanisms of the antiproteinuric effect of MK-591, a leukotriene biosynthesis inhibitor, in human glomerulonephritis.
    Guasch, A
    Zayas, CF
    Badr, KF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0412 - A0412
  • [40] Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591
    Roberts, WG
    Simon, TJ
    Berlin, RG
    Haggitt, RC
    Snyder, ES
    Stenson, WF
    Hanauer, SB
    Reagan, JE
    Cagliola, A
    Tanaka, WK
    Simon, S
    Berger, ML
    GASTROENTEROLOGY, 1997, 112 (03) : 725 - 732
12345